Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 13, 2022

SELL
$75.08 - $121.99 $375 - $609
-5 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$130.4 - $225.58 $652 - $1,127
5 New
5 $1,000
Q1 2021

Apr 14, 2021

SELL
$124.11 - $190.17 $620 - $950
-5 Closed
0 $0
Q3 2020

Oct 08, 2020

BUY
$58.05 - $111.31 $290 - $556
5 New
5 $1,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.86B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Sound Income Strategies, LLC Portfolio

Follow Sound Income Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Income Strategies, LLC with notifications on news.